Tag: CoviTRAP
Chula Researchers DiscoverHighly Effective Antibodies against COVID-19, ‘Leading to COVITRAP Nasal Spray’ to Curb Infection at the Start
A research team at the Center of Excellence in Systems Biology, Faculty of Medicine, Chulalongkorn University, has identified “highly effective antibodies against COVID-19” from the human body. These antibodies have been developed into an innovation called “COVITRAP,” the world’s first nasal spray that traps and inhibits the COVID-19 virus using antibodies. This spray has been certified as a medical device, and the team is confident in its efficacy for dealing with COVID-19 alongside other preventive measures.
CoviTRAP Anti-COVID Spray Now Available
BANGKOK, Oct 4 (TNA) – Locally made anti-COVID-19 nasal spray with six-hour protection is now available at the outlets of the Government Pharmaceutical Organization (GPO) [Read More…]
Anti-COVID nasal spray to be available from October 1st
An anti-COVID nasal spray, an innovation jointly developed by Health Systems Research Institute (HSRI), the Faculty of Medicine at Chulalongkorn University, the Government Pharmaceutical Organization [Read More…]
Two nasal spray COVID-19 vaccines under development by Thailand’s BIOTEC
Thai virologists, at the National Centre for Genetic Engineering and Biotechnology (BIOTEC), have been developing two candidate nasal spray vaccines, or vaccine inhalers, which they [Read More…]
